Hello Everyone,
I developed a nitrosamine method for a drug product. The recovery is 75%. This recovery is acceptable according to USP 1469. However, I have a question about this.
Should I use a recovery factor? I haven’t seen any information in any guides regarding the use of a recovery factor. Do I have to use it because the recovery is low, or can I report without using it?
Thank you.